Binnacle Investments Inc Intra Cellular Therapies, Inc. Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Binnacle Investments Inc holds 84 shares of ITCI stock, worth $11,077. This represents 0.01% of its overall portfolio holdings.
Number of Shares
84Holding current value
$11,077% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
419Shares Held
68.1MCall Options Held
934KPut Options Held
758K-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$402 Million3.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT2MShares$264 Million7.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...